CFO of ONYX Pharmaceuticals Inc. (ONXX, Financial) Matthew K Fust sells 1,789 shares of ONXX on 01/06/2012 at an average price of $43.46 a share.
Onyx Pharmaceuticals Inc. has a market cap of $2.81 billion; its shares were traded at around $44.18 with and P/S ratio of 8.7.
For the complete insider trading history of ONXX, click here.
Onyx Pharmaceuticals Inc. has a market cap of $2.81 billion; its shares were traded at around $44.18 with and P/S ratio of 8.7.
CFO Recent Trades:
- CFO Matthew K Fust sold 867 shares of ONXX stock on 11/18/2011 at the average price of 38.05. Matthew K Fust owns at least 45,310 shares after this. The price of the stock has increased by 16.11% since.
Directors and Officers Recent Trades:
- EVP, Corporate Development Juergen Lasowski sold 1,232 shares of ONXX stock on 01/03/2012 at the average price of 42.64. Juergen Lasowski owns at least 34,000 shares after this. The price of the stock has increased by 3.61% since.
- SVP, Global Human Resources Kaye I Foster-cheek sold 29,500 shares of ONXX stock on 12/05/2011 at the average price of 43.56. Kaye I Foster-cheek owns at least 27,914 shares after this. The price of the stock has increased by 1.42% since.
- VP, Public Affairs Julianna R Wood sold 107,053 shares of ONXX stock on 11/28/2011 at the average price of 45. Julianna R Wood owns at least 16,597 shares after this. The price of the stock has decreased by 1.82% since.
- Director Wendall Wierenga sold 250 shares of ONXX stock on 11/01/2011 at the average price of 39.37. Wendall Wierenga owns at least 5,830 shares after this. The price of the stock has increased by 12.22% since.
- EVP, Corporate Affairs Laura Brege sold 10,000 shares of ONXX stock on 10/14/2011 at the average price of 36.01. Laura Brege owns at least 39,670 shares after this. The price of the stock has increased by 22.69% since.
For the complete insider trading history of ONXX, click here.
